What is Sarah Lasala's NPI number?

Sarah Lasala's National Provider Identifier (NPI) is 1205327566, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Sarah Lasala's specialty?

Sarah Lasala is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).

Where is Sarah Lasala located?

Sarah Lasala's practice location on file with NPPES is 113 Elm St Ste 304, Enfield, CT 06082-3739.

What is Sarah Lasala's phone number?

The practice phone number listed in the NPPES registry for Sarah Lasala is (860) 741-2225.

Does Sarah Lasala accept Medicare?

Sarah Lasala is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Sarah Lasala's NPI active?

Yes — Sarah Lasala's NPI (1205327566) is active in the NPPES registry as of the last update on 2024-04-18.

IndividualActiveAccepts Medicare

Sarah Lasala, PA-C

NPI 1205327566 · Physician Assistant · Enfield, CT

Sarah Lasala, PA-C is a Physician Assistant provider in Enfield, CT (NPI 1205327566).

Provider details

NPI number: 1205327566
Entity type: Individual
Primary specialty: Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
Credential: PA-C
Sex: Female
Sole proprietor: Yes

Practice location

113 Elm St Ste 304

Enfield, CT 06082-3739

Phone: (860) 741-2225

Fax: (860) 741-2229

Street-level locationGet directions

More CT providers

Mailing address

113 Elm St Ste 304

Enfield, CT 06082-3739

Specialties & taxonomies

Physician AssistantPrimary363A00000XLicense 2153 (WV)
Physician Assistants & Advanced Practice Nursing Providers
Medical Physician Assistant363AM0700X
Physician Assistants & Advanced Practice Nursing Providers

Additional practice locations (1)

714 Hopmeadow St Ste 5
Simsbury, CT 06070-2234
Phone: (860) 741-2225
Fax: (860) 651-1404

Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(78/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
8 yrs in NPPES registry
Profile completeness25% of score
83% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
1,009 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	340	$118
Destruction of Precancer Skin Growth, 2-14 Growths17003	212	$6
Biopsy of Related Skin Growth, First Growth11102	125	$89
Destruction of Precancer Skin Growth, 1 Growth17000	95	$51
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	83	$154
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	121	87
Fluorouracil	49	44
Triamcinolone Acetonide	46	39
Clobetasol Propionate	41	32
Nystatin	18	12

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,034 across 79 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2018-05-22
Last updated: 2024-04-18
Certified: 2024-04-18

Frequently asked questions

What is Sarah Lasala's NPI number?: Sarah Lasala's National Provider Identifier (NPI) is 1205327566, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Sarah Lasala's specialty?: Sarah Lasala is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
Where is Sarah Lasala located?: Sarah Lasala's practice location on file with NPPES is 113 Elm St Ste 304, Enfield, CT 06082-3739.
What is Sarah Lasala's phone number?: The practice phone number listed in the NPPES registry for Sarah Lasala is (860) 741-2225.
Does Sarah Lasala accept Medicare?: Sarah Lasala is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Sarah Lasala's NPI active?: Yes — Sarah Lasala's NPI (1205327566) is active in the NPPES registry as of the last update on 2024-04-18.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	340	$118
Destruction of Precancer Skin Growth, 2-14 Growths17003	212	$6
Biopsy of Related Skin Growth, First Growth11102	125	$89
Destruction of Precancer Skin Growth, 1 Growth17000	95	$51
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	83	$154
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	121	87
Fluorouracil	49	44
Triamcinolone Acetonide	46	39
Clobetasol Propionate	41	32
Nystatin	18	12

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,034 across 79 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments